1. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections;Shiraki;Pharmacol. Ther.,2020
2. Favipiravir for the Treatment of COVID-19,2020
3. Favipiravir versus arbidol for clinical recovery rate in moderate and severe adult COVID-19 patients: a prospective, multicenter, open-label, randomized controlled clinical trial;Chen;Front. Pharmacol.,2021
4. others, Experimental treatment with favipiravir for COVID-19: an open-label control study;Cai;Engineering,2020
5. Favipiravir: a new and emerging antiviral option in COVID-19;Agrawal;Med. J. Armed Forces India,2020